Literature DB >> 17574040

Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells.

Joel Baumgartner1, Cara Wilson, Brent Palmer, Don Richter, Anirban Banerjee, Martin McCarter.   

Abstract

BACKGROUND: The immune response to melanoma is rarely curative, suggesting the emergence of immunosuppression. FOXP3-expressing regulatory T cells (T(reg) cells) function to suppress immune responses. The objective of this study was to determine if melanoma evades immune surveillance, in part, by inducing T(reg) cells.
MATERIAL AND METHODS: Peripheral blood mononuclear cells (PBMCs) were isolated and exposed to melanoma-conditioned media (MCM) or control media for 1 week. The induction of T(reg) cells in these PBMCs was determined by measuring the proportion of CD25(+)FOXP3(+) T cells in all CD4(+) T cells by flow cytometry. FOXP3 expression was determined by mean fluorescence intensity (MFI) and Western blot. Supernatant cytokines were determined by ELISA.
RESULTS: Normal PBMCs exposed to MCM revealed higher proportions of T(reg) cells than those exposed to control media after 6 days (3.4% versus 1.3%, respectively, P < 0.02). The expression of FOXP3 in T(reg) cells from PBMCs exposed to MCM increased over time by MFI and Western blot but was not significantly different than those exposed to control media. The level of IL-10 and TGF-beta in supernatants after 6 days growth was higher in MCM than control media, but this did not reach statistical significance.
CONCLUSION: Exposure of PBMCs to melanoma results in induction of FOXP3(+) T(reg) cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574040      PMCID: PMC2043471          DOI: 10.1016/j.jss.2007.03.053

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  32 in total

1.  Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma.

Authors:  Christian P Gray; Paolo Arosio; Peter Hersey
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 12.531

2.  IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin.

Authors:  Rachael A Clark; Thomas S Kupper
Journal:  Blood       Date:  2006-09-12       Impact factor: 22.113

3.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

4.  Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

Authors:  S A Rosenberg; B S Packard; P M Aebersold; D Solomon; S L Topalian; S T Toy; P Simon; M T Lotze; J C Yang; C A Seipp
Journal:  N Engl J Med       Date:  1988-12-22       Impact factor: 91.245

5.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

6.  Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.

Authors:  Fumiko Ichihara; Koji Kono; Akihiro Takahashi; Hiromichi Kawaida; Hidemitsu Sugai; Hideki Fujii
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

7.  Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells.

Authors:  Manuelle Viguier; Fabrice Lemaître; Olivier Verola; Min-Sun Cho; Guy Gorochov; Louis Dubertret; Hervé Bachelez; Philippe Kourilsky; Laurent Ferradini
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

8.  Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic.

Authors:  D L Morton; L Wanek; J A Nizze; R M Elashoff; J H Wong
Journal:  Ann Surg       Date:  1991-10       Impact factor: 12.969

9.  CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression.

Authors:  Tetsuro Sasada; Motohide Kimura; Yuka Yoshida; Michiyuki Kanai; Arimichi Takabayashi
Journal:  Cancer       Date:  2003-09-01       Impact factor: 6.860

Review 10.  Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis.

Authors:  Eleonora Gambineri; Troy R Torgerson; Hans D Ochs
Journal:  Curr Opin Rheumatol       Date:  2003-07       Impact factor: 5.006

View more
  24 in total

1.  DC maturation and function are not altered by melanoma-derived immunosuppressive soluble factors.

Authors:  Joel M Baumgartner; Kimberly R Jordan; Ling-Jia Hu; Cara C Wilson; Anirban Banerjee; Martin D McCarter
Journal:  J Surg Res       Date:  2011-08-24       Impact factor: 2.192

Review 2.  Regulatory T cells in the immunotherapy of melanoma.

Authors:  Zhengxiao Ouyang; Hongwei Wu; Linqin Li; Yi Luo; Xianan Li; Gang Huang
Journal:  Tumour Biol       Date:  2015-10-30

3.  Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697).

Authors:  Lisa H Butterfield; Fengmin Zhao; Sandra Lee; Ahmad A Tarhini; Kim A Margolin; Richard L White; Michael B Atkins; Gary I Cohen; Theresa L Whiteside; John M Kirkwood; David H Lawson
Journal:  Clin Cancer Res       Date:  2017-05-23       Impact factor: 12.531

4.  T Regulatory Cell Induced Foxp3 Binds the IL2, IFNγ, and TNFα Promoters in Virus-Specific CD8+ T Cells from Feline Immunodeficiency Virus Infected Cats.

Authors:  Yan Wang; Mukta Nag; Joanne L Tuohy; Kristina De Paris; Jonathan E Fogle
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11-17       Impact factor: 2.205

5.  Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts.

Authors:  Sankar Bhattacharyya; Dewan Md Sakib Hossain; Suchismita Mohanty; Gouri Sankar Sen; Sreya Chattopadhyay; Shuvomoy Banerjee; Juni Chakraborty; Kaushik Das; Diptendra Sarkar; Tanya Das; Gaurisankar Sa
Journal:  Cell Mol Immunol       Date:  2010-03-22       Impact factor: 11.530

6.  Sex Differences in Melanoma.

Authors:  Matthew Robert Schwartz; Li Luo; Marianne Berwick
Journal:  Curr Epidemiol Rep       Date:  2019-05-31

Review 7.  Melanoma in immunosuppressed patients.

Authors:  Agnieszka W Kubica; Jerry D Brewer
Journal:  Mayo Clin Proc       Date:  2012-10       Impact factor: 7.616

Review 8.  Cancer stem cells and human malignant melanoma.

Authors:  Tobias Schatton; Markus H Frank
Journal:  Pigment Cell Melanoma Res       Date:  2008-02       Impact factor: 4.693

Review 9.  Regulatory T cells and treatment of cancer.

Authors:  Tyler J Curiel
Journal:  Curr Opin Immunol       Date:  2008-05-27       Impact factor: 7.486

10.  Regulatory T Cells Play an Important Role in the Prevention of Murine Melanocytic Nevi and Melanomas.

Authors:  Laura Timares; Craig A Elmets; Tahseen H Nasti; Nabiha Yusuf; Mohammad Asif Sherwani; Mohammad Athar
Journal:  Cancer Prev Res (Phila)       Date:  2020-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.